What would you say?

If you could say anything to someone designing a drug trial for Celiac disease, what would you say? With the stopping of the Nexvax trial and the upcoming Phase 3 trial of Larazotide acetate (INN-202), these are two completely different trials with completely different information being gathered. Nexvax had lots of blood tests, daily surveys … Continue reading What would you say?